Wang Tsung-Han, Hsu Yin-Chou
Department of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung 82445, Taiwan.
School of Medicine for International Student, I-Shou University, Kaohsiung 82445, Taiwan.
Diagnostics (Basel). 2021 Aug 14;11(8):1474. doi: 10.3390/diagnostics11081474.
Sepsis remains the leading cause of death in critically ill patients. Thus, regular measurement of lactate levels has been proposed in sepsis guidelines. Elevated red cell distribution width (RDW) is associated with mortality risk in patients with sepsis. This study aimed to investigate the association between RDW and the risk of other adverse outcomes in patients with sepsis and to compare the mortality discriminative ability between lactate and RDW levels. This is a single-centered, retrospective, case-control study that included 504 adult patients with sepsis in the emergency department between 1 January 2020 and 31 December 2020. Eligible patients were divided into normal (RDW ≤ 14.5%) and high (RDW > 14.5%) groups. The baseline characteristics and adverse outcomes were recorded and compared. Compared with the normal RDW group, the patients in the high RDW group had a significantly higher rate of ICU admission (48.8% vs. 32.4%, = 0.03), septic shock (39.2% vs. 23.5%, < 0.01), and 30-day in-hospital mortality (32.0% vs. 20.7%, < 0.01). Furthermore, the RDW (area under curve (AUC) = 0.71) had superior mortality discriminative ability compared to lactate (AUC = 0.63) levels ( = 0.02). Clinicians could rely on this simple and rapid parameter for risk stratification to initiate prompt treatment for patients with sepsis.
脓毒症仍然是重症患者死亡的主要原因。因此,脓毒症指南中建议定期测量乳酸水平。红细胞分布宽度(RDW)升高与脓毒症患者的死亡风险相关。本研究旨在探讨脓毒症患者RDW与其他不良结局风险之间的关联,并比较乳酸水平与RDW水平在死亡率判别能力上的差异。这是一项单中心、回顾性病例对照研究,纳入了2020年1月1日至2020年12月31日期间急诊科的504例成年脓毒症患者。符合条件的患者分为正常(RDW≤14.5%)组和高(RDW>14.5%)组。记录并比较基线特征和不良结局。与正常RDW组相比,高RDW组患者的ICU入住率(48.8%对32.4%,P=0.03)、脓毒性休克发生率(39.2%对23.5%,P<0.01)和30天院内死亡率(32.0%对20.7%,P<0.01)显著更高。此外,RDW(曲线下面积[AUC]=0.71)在死亡率判别能力上优于乳酸水平(AUC=0.63)(P=0.02)。临床医生可以依靠这个简单快速的参数进行风险分层,以便对脓毒症患者及时展开治疗。